Mein Warenkorb

GDF-8

GDF-8 Molekülinformation

Englischer NameGrowth/differentiation factor 8Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel8Target-AliasMSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Höchste Forschungs- und EntwicklungsphaseNDA/BLA
Englischer NameGrowth/differentiation factor 8
Target-AliasMSTN,GDF-8,GDF8,Growth Differentiation Factor 8,MSLHP,Myostatin,Growth/Differentiation Factor 8
Anzahl der inverkehr gebrachten Arzneimittel0
Anzahl der klinischen Arzneimittel8
Höchste Forschungs- und EntwicklungsphaseNDA/BLA

GDF-8 Molekülhintergrund

Growth differentiation factor 8 (GDF8), also known as myostatin, is a unique member of the transforming growth factor-β superfamily that is expressed in human granulosa cells and has important roles in regulating a variety of ovarian functions. GDF8 acts as a negative regulator of skeletal muscle growth and differentiation. In addition to the expression in the musculoskeletal system, GDF8 is also expressed in various tissues, including the reproductive system.

GDF-8 Molekülalias

GDF-8, Myostatin, GDF8, MSTN, Growth,differentiation factor 8

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Talditercept alfaRO-7239361; BMS-986089; RG-6206; BHV-2000Phase 3 ClinicalBristol-Myers Squibb CompanyMuscular Atrophy, Spinal; Muscular Dystrophy, Duchenne; Neuromuscular Diseases; Obesity; Overweight
Details
EmugrobartGYM-329; RG-6237; RG-70240; RO-7204239Phase 3 ClinicalChugai Pharmaceutical Co LtdDiabetes Mellitus, Type 2; Muscular Atrophy, Spinal; Muscular Dystrophy, Facioscapulohumeral; Obesity; Overweight
Details
TrevogrumabREGN-1033; REGN1033; SAR-391786; GDF8Phase 2 ClinicalRegeneron Pharmaceuticals IncMyositis, Inclusion Body; Obesity; Sarcopenia
Details
AAV1-FS344AAV1-Follistatin; AAV1-FS344Phase 2 ClinicalNationwide Children'S HospitalBecker muscular dystrophy; Muscular Dystrophy, Duchenne; Myositis, Inclusion Body
Details
EL-22EL-22Phase 1 ClinicalObesity
Details
IBIO-600IBIO-600Phase 1 ClinicalAstralBio IncObesity; Overweight
Details
RinvaterceptRKER-065; KER-065Phase 1 ClinicalKeros Therapeutics IncNeuromuscular Diseases; Obesity
Details
SRK-439SRK-439Phase 1 ClinicalScholar Rock IncHeart Diseases; Obesity
Details
  • Molekülinformation
  • Produktliste
  • Klinische Arzneimittelinformation
Kontaktieren Sie uns